Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

5.62USD
23 Aug 2019
Change (% chg)

$-0.12 (-2.09%)
Prev Close
$5.74
Open
$5.69
Day's High
$5.76
Day's Low
$5.44
Volume
194,852
Avg. Vol
188,415
52-wk High
$21.48
52-wk Low
$4.17

Wolin, Benjamin 

Mr. Benjamin Wolin has been appointed Lead Independent Director of Diplomat Pharmacy, Previously, Mr. Wolin served as independent Lead Director from February 2017 to January 2018 and as Chairman of the Board from January 2018 until June 2018. Mr. Wolin was the Co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc., a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001, Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies. In March 2018, Mr. Wolin was appointed to the board of Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company, where he serves as Chairman of the Board and as a member of the Compensation Committee. In February 2019, Mr. Wolin was appointed to the board of Covetrus, Inc. (Nasdaq: CVET), a global, technology-enabled animal health business, where he serves as a member of the Compensation Committee and a member of the Strategy Committee.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 128,263
Long-Term Incentive Plans, USD --
All Other, USD 129,895
Fiscal Year Total, USD 258,158

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --